NCT05240040 2026-03-23
Treat Primary and Metastatic Liver Tumors
Methodist Health System
Withdrawn
Clinical Trials
127 trialsNCT06217094 2026-02-18
Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment
University of Florida
Phase 1 Withdrawn
NCT06994299 2025-11-18
PRISM
Weill Medical College of Cornell University
Phase 2 Withdrawn
NCT06361758 2025-05-23
Second-line Treatment With CAdonilimab and LEnvatinib for Unresectable HCC
Shanghai Zhongshan Hospital
Phase 2 Withdrawn
NCT02939807 2025-04-27
A Phase II Study of ABC294640 as Monotherapy in Patients With Advanced Hepatocellular Carcinoma
Medical University of South Carolina
Phase 2 Withdrawn
NCT03636607 2025-03-24
Diagnostic Significance of Single Center, Open and Prospective Evaluation of <Sup>18<Sup>F-FDG PET/CT Dynamic Imaging and Genomic Sequencing in Detecting Metastatic Lesions of Primary Hepatocellular Carcinoma
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase NA Withdrawn
NCT04976660 2025-03-18
TT-4 As a Single Agent in Subjects with Advanced Selected Solid Tumors
Portage Biotech
Phase 1/2 Withdrawn
NCT04791228 2025-01-01
A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors
Children's National Research Institute
Phase 2 Withdrawn
NCT04985357 2024-11-25
Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs
Travera Inc
Withdrawn
NCT05418387 2024-11-25
A Social Support Intervention to Improve Treatment Among Hispanic Kidney and Liver Cancer Patients in Arizona
University of Arizona
Phase NA Withdrawn
NCT00756782 2024-09-04
A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular Carcinoma
Taiho Oncology, Inc.
Phase 2 Withdrawn
NCT05211388 2024-08-29
Treat-and-resect Study of Echo Decorrelation Imaging-controlled Radiofrequency Ablation in Liver Tumors
University of Cincinnati
Phase NA Withdrawn
NCT06006286 2024-08-26
A Study Evaluating Atezolizumab and Bevacizumab Plus ADI-PEG 20 in Patients With Locally Advanced / Metastatic Hepatocellular Carcinoma
M.D. Anderson Cancer Center
Phase 1/2 Withdrawn
NCT06337162 2024-08-09
HCC
Abramson Cancer Center at Penn Medicine
Phase 1 Withdrawn
NCT05292443 2024-02-23
Therapeutic ResistAnce and Clonal Evolution Assessed With Liquid Biopsy in ICIs Treated Primary Liver Cancer
Geneplus-Beijing Co. Ltd.
Withdrawn
NCT05641922 2023-11-27
PANORAMA2
Techsomed Medical Technologies LTD
Phase NA Withdrawn
NCT05111314 2023-11-07
Comparison of Hepatic Intraarterial Versus Systemic Intravenous 68Ga-PSMA PET/CT for Detection of Hepatocellular Carcinoma
Mayo Clinic
Phase EARLY_PHASE1 Withdrawn
NCT05109052 2023-07-13
Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma
University of Rochester
Phase 1/2 Withdrawn
NCT03722498 2023-07-11
Phase â…¡ Study of HAIC of FOLFOX vs. Sorafenib in HCC Refractory to TACE
Sun Yat-sen University
Phase 2 Withdrawn
NCT05564338 2023-06-07
Efficacy and Safety of Sitravatinib Plus Tislelizumab or Placebo Plus Tislelizumab Versus Placebo as Adjuvant Treatment in Participants With Hepatocellular Carcinoma
BeiGene
Phase 3 Withdrawn
NCT05886257 2023-06-02
Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T
Sun Yat-sen University
Phase 2 Withdrawn
NCT05039736 2023-05-12
A Phase II Study to Evaluate the Effects of Sequential Therapy With the Anti c-MET/VEGFR Tyrosine Kinase Inhibitor (TKI), Cabozantinib, Followed by an Anti-PD-1 Antibody (Nivolumab) in Patients With Advanced HCC Who Progressed on First-line Therapy
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT02174575 2023-05-03
Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery
Tokyo Medical and Dental University
Phase 4 Withdrawn
NCT05157451 2023-03-23
Y-90 Versus SBRT for Inoperable HCC
OHSU Knight Cancer Institute
Phase 2 Withdrawn
NCT02899325 2023-02-21
FDGal PET/CT to Detect Hepatocellular Carcinoma
British Columbia Cancer Agency
Withdrawn
NCT05628545 2023-01-18
Adoptive Treatment of Advanced Hepatocellular Carcinoma With Allogeneic γδ-T Cells
Guangdong GD Kongming Biotech LLC
Phase 1/2 Withdrawn
NCT04178642 2022-12-14
LIDA-ADJ
University Hospital, Montpellier
Phase 2 Withdrawn
NCT05327738 2022-12-14
Yttrium Y 90 Glass Microspheres, Atezolizumab, and Cabozantinib for the Treatment of Unresectable or Locally Advanced Hepatocellular Carcinoma
OHSU Knight Cancer Institute
Phase 2 Withdrawn
NCT04775056 2022-08-03
A Study to Evaluate Vaccines Against COVID-19 in the Real World
Humanity & Health Medical Group Limited
Withdrawn
NCT03634683 2022-06-30
A Study of LioCyx in Patient With Recurrent HBV-related HCC Post Liver Transplantation
Lion TCR Pte. Ltd.
Phase 1/2 Withdrawn
NCT04190498 2022-05-24
ECHAPS
University Hospital, Grenoble
Withdrawn
NCT04465734 2022-05-05
A Clinical Study to Compare the Efficacy and Safety of HLX10 in Combination With HLX04 Versus Sorafenib as the First-line Treatment in Patients With Locally Advanced or Metastatic HCC
Shanghai Henlius Biotech
Phase 3 Withdrawn
NCT04231929 2022-03-28
BIOPEARL-FIRST
Terumo Europe N.V.
Phase NA Withdrawn
NCT03908255 2022-01-28
BCAA in HCC
Louisiana State University Health Sciences Center in New Orleans
Phase 2 Withdrawn
NCT04947371 2021-07-01
Adjuvant Therapy With Anlotinib for HCC
Shanghai Zhongshan Hospital
Phase 2 Withdrawn
NCT03452553 2021-04-21
Study in the Treatment of HCC With a Radiopaque (RO) Bead (LC Bead LUMIâ„¢) Loaded With Doxorubicin
Boston Scientific Corporation
Phase NA Withdrawn
NCT00892255 2021-04-02
Microwave Ablation of Resectable Liver Tumors
St. Joseph Hospital of Orange
Withdrawn
NCT04404647 2021-03-26
Irreversible Electroporation of Unresectable Liver Tumors
Aalborg University Hospital
Phase NA Withdrawn
NCT04526080 2021-02-26
TheraBionics
Wake Forest University Health Sciences
Phase 2 Withdrawn
NCT02129322 2021-02-15
Effect of Adjuvant Therapy by Sorafenib, Oxaliplatin and S-1
Zhejiang University
Phase 2 Withdrawn
NCT03215355 2021-01-27
Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium
Nova Scotia Health Authority
Phase 4 Withdrawn
NCT03040453 2020-11-30
IRAL
Karolinska Institutet
Phase NA Withdrawn
NCT03063840 2020-11-20
Microwave Ablation for the Treatment of Malignant Liver Tumors Closed to Intrahepatic Vessels
National Taiwan University Hospital
Phase NA Withdrawn
NCT04270461 2020-10-22
NKG2D-based CAR T-cells Immunotherapy for Patient With r/r NKG2DL+ Solid Tumors
Jiujiang University Affiliated Hospital
Phase 1 Withdrawn
NCT02558205 2020-10-08
Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry
Rush University Medical Center
Withdrawn
NCT04044326 2020-09-14
The Safety and Efficacy of Spherical Microwave Ablation for the Treatment of Malignant Liver Tumors
National Taiwan University Hospital
Phase NA Withdrawn
NCT04546802 2020-09-14
HATCHeT
Bayside Health
Phase 3 Withdrawn
NCT03172559 2020-08-20
RADBRI
University Health Network, Toronto
Phase NA Withdrawn
NCT00020774 2020-07-31
SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Withdrawn
NCT02723942 2020-07-16
CAR-T Cell Immunotherapy for HCC Targeting GPC3
Fuda Cancer Hospital, Guangzhou
Phase 1/2 Withdrawn